Gangadhar Garipelli
About Gangadhar Garipelli
Gangadhar Garipelli serves as the Director of Clinical Development for Digital Therapeutics at MindMaze in Lausanne, Switzerland, where he has worked since 2012. He possesses over 14 years of experience in neuroengineering and has a strong academic background in neuroscience and engineering.
Work at MindMaze
Gangadhar Garipelli has served as the Director of Clinical Development for Digital Therapeutics at MindMaze since 2012. In this role, he focuses on constructing and executing a clinical evidence pipeline through randomized clinical trials globally. His work primarily targets neurorehabilitation for various conditions, including post-stroke recovery, Parkinson’s disease, Alzheimer’s disease, aging, and pain management. Additionally, he is involved in corporate development and strategy, including mergers and acquisitions, contributing to the company's growth and innovation in the field of digital therapeutics.
Education and Expertise
Gangadhar Garipelli holds extensive academic qualifications in neuroengineering and related fields. He completed his Bachelor of Technology in Electronics and Communications Engineering at Jawaharlal Nehru Technological University from 1999 to 2003. He then pursued a Master of Science in Computational Neuroscience at the Indian Institute of Technology, Madras, from 2004 to 2006. Following this, he earned a Doctor of Science in Brain Computer Interfacing from École polytechnique fédérale de Lausanne (EPFL) between 2006 and 2011. He also completed a postdoctoral program at EPFL in 2012, focusing on neuroengineering.
Background
Before joining MindMaze, Gangadhar Garipelli worked as a Research Assistant at EPFL from 2006 to 2011. During this time, he gained valuable experience in neuroengineering, artificial intelligence, and machine learning. His academic and professional background has equipped him with over 14 years of experience in applying these technologies to neurorehabilitation and neuroprosthetics, positioning him as a knowledgeable figure in the field.
Achievements
Gangadhar Garipelli has strategically constructed and executed a clinical evidence pipeline through randomized clinical trials worldwide, focusing on neurorehabilitation. His efforts contribute to advancing treatments for conditions such as post-stroke recovery, Parkinson’s disease, Alzheimer’s disease, aging, and pain management. His involvement in corporate development and strategy at MindMaze highlights his role in shaping the future of digital therapeutics.